• HOME
  • RECRUITMENT
    • WHY RECRUIT WITH US
    • PROVEN PROCESS
    • EXPERTISE AND EXPERIENCE
    • NETWORK OF CANDIDATES
    • EXECUTIVE RECRUITING
    • REQUEST MORE INFORMATION
    • SLONEXTRAS
  • ABOUT US
    • MISSION, VISION & VALUES
    • EXECUTIVE BIOS
    • ADVISORY BOARD
    • TESTIMONIALS
    • SLONE CARES
    • INDUSTRY INVOLVEMENT
  • SLONE NEWS
    • LATEST NEWS
    • PRESS RELEASES
    • NEWSLETTER
    • INDUSTRY HEADLINES
    • UPCOMING EVENTS
    • DIAGNOSTIC LABORATORY NEWS
  • CANDIDATES
  • FEATURED POSITIONS
  • COMPLETED SEARCHES
  • CONTACT US
Apycom jQuery Menus

Monthly Archives: April 2012

Post navigation

← Older posts

Two chromosomal variants connected to glaucoma

Posted on April 30, 2012 by Zach Helminiak at Slone Partners
Reply

Eventually, new treatments can be developed so that patients can begin receiving care before their vision becomes affected. Continue reading →

Posted in Personalized Medicine | Leave a reply

Researchers tie genetic markers to bone health

Posted on April 27, 2012 by Zach Helminiak at Slone Partners
Reply

The research found that some patients with specific genetic variants were up to 60 percent more likely to experience bone fractures. Continue reading →

Posted in Personalized Medicine | Leave a reply

Genetic testing could help families better plan for child birth

Posted on April 25, 2012 by Zach Helminiak at Slone Partners
Reply

Three specific genetic markers may be able to predict when a woman’s chances of conceiving a child begin to decline. Continue reading →

Posted in Genomics | Leave a reply

Researchers identify six more breast cancer genetic subtypes

Posted on April 24, 2012 by Zach Helminiak at Slone Partners
Reply

By knowing which type of cancer a patient has contracted, doctors can pinpoint how the disease is likely to progress, possible treatments and a patient’s prognosis for survival. Continue reading →

Posted in Anatomic Pathology | Leave a reply

Innovative startups expand considerably in light of lower sequencing costs

Posted on April 23, 2012 by Zach Helminiak at Slone Partners
Reply

The task of sequencing and analyzing genetic information is far more intricate than some originally assumed. Continue reading →

Posted in Genomics | Leave a reply

Medical and digital worlds still learning to work with one another

Posted on April 20, 2012 by Zach Helminiak at Slone Partners
Reply

Consumers may eventually come to expect personalized treatments when they see their doctor. Continue reading →

Posted in Personalized Medicine | Leave a reply

Procedure uses genes to reprogram scar tissue after heart attack

Posted on April 19, 2012 by Zach Helminiak at Slone Partners
Reply

Because of the complicated nature of a heart transplant, it trails only an intestine transplant in terms of sheer cost. Continue reading →

Posted in Personalized Medicine | Leave a reply

Specific gene may hold key to treating form of leukemia

Posted on April 16, 2012 by Zach Helminiak at Slone Partners
Reply

Researchers were able to sequence the FLT3 gene, which they found to be more susceptible to treatments intended to combat acute myeloid leukemia. Continue reading →

Posted in Anatomic Pathology | Leave a reply

Experimental Parkinson’s treatment involves gene therapy

Posted on April 13, 2012 by Zach Helminiak at Slone Partners
Reply

Roy said that before receiving the treatment, she frequently experienced bouts of uncontrollable and violent seizures, often occurring without much warning. Continue reading →

Posted in Personalized Medicine | Leave a reply

Two gene variations contribute to PTSD symptoms

Posted on April 11, 2012 by Zach Helminiak at Slone Partners
Reply

The two genes associated with PTSD – TPH1 and TPH2 – regulate the production of serotonin, which is responsible for many aspects of a person’s mood. Continue reading →

Posted in Genomics | Leave a reply

Post navigation

← Older posts
Contact Us
Company Name:
* Contact Name:
* Contact Phone Number:
* Contact Email Address:
Comments:
CAPTCHA Image [ Different Image ]

Popular Posts

  • Genetic testing spending expected to increase by five times in next decade
  • Gawande in The New Yorker: Hospitals and the Efficiency of Restaurant Chains
  • Conversation with David A. Dexter of Sonora Quest Laboratories
  • The Genomic Revolution on TEDx
  • Negative side effects from drugs avoidable through personalized medicine

Subscribe To Slone News

Last Name
email
 
     SLONEPARTNERS.COM © 2011